Shuttle Pharmaceuticals Holdings Current Ratio Growth & History (SHPH)
Shuttle Pharmaceuticals Holdings's current ratio was 0.06 for fiscal 2025.
View full Shuttle Pharmaceuticals Holdings company overviewShuttle Pharmaceuticals Holdings annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.06 | −1.38 | −95.62% |
| 2024 | 2024-12-31 | 1.44 | −3.92 | −73.14% |
| 2023 | 2023-12-31 | 5.37 | −3.43 | −38.96% |
| 2022 | 2022-12-31 | 8.79 | 8.56 | +3725.49% |
| 2021 | 2021-12-31 | 0.23 | — | — |
Shuttle Pharmaceuticals Holdings quarterly current ratio
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | 0.30 | −2.49 | −89.34% |
| Q4 2025 | 2025-12-31 | 0.06 | −1.38 | −95.62% |
| Q3 2025 | 2025-09-30 | 1.66 | 1.44 | +663.20% |
| Q2 2025 | 2025-06-30 | 3.07 | 1.27 | +70.87% |
| Q1 2025 | 2025-03-31 | 2.78 | −0.18 | −6.05% |
| Q4 2024 | 2024-12-31 | 1.44 | −3.92 | −73.14% |
| Q3 2024 | 2024-09-30 | 0.22 | −8.41 | −97.48% |
| Q2 2024 | 2024-06-30 | 1.79 | −15.31 | −89.50% |
| Q1 2024 | 2024-03-31 | 2.96 | −4.51 | −60.35% |
| Q4 2023 | 2023-12-31 | 5.37 | −3.43 | −38.96% |
| Q3 2023 | 2023-09-30 | 8.63 | −0.94 | −9.82% |
| Q2 2023 | 2023-06-30 | 17.10 | — | — |
| Q1 2023 | 2023-03-31 | 7.47 | — | — |
| Q4 2022 | 2022-12-31 | 8.79 | 8.56 | +3725.49% |
| Q3 2022 | 2022-09-30 | 9.57 | — | — |
| Q4 2021 | 2021-12-31 | 0.23 | — | — |
Shuttle Pharmaceuticals Holdings current ratio trends
Between the periods ended 2021-12-31 and 2025-12-31, Shuttle Pharmaceuticals Holdings's current ratio decreased from 0.23 to 0.06, a change of −0.17. The latest reported quarter, Q1 2026, shows 0.30.
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Shuttle Pharmaceuticals Holdings source filings ↗